Drug intelligence / Profile preview

esterified estrogens + methyltestosterone

Development stage
Discontinued
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Esterified estrogens + methyltestosterone is a combination oral medication containing two hormones—esterified estrogens (a mixture of synthetic estrogen compounds) and methyltestosterone (a synthetic androgen). It is primarily used for the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who do not achieve adequate relief from estrogen therapy alone. The drug works by supplementing declining endogenous hormone levels during menopause to alleviate symptoms such as hot flashes and vaginal dryness. Esterified estrogens act as agonists at the estrogen receptor to restore estrogenic activity in target tissues. Methyltestosterone acts as an agonist at the androgen receptor to provide additional hormonal support that may further reduce menopausal symptoms[1][2][4][5]. This combination product has been marketed under several brand names but has been discontinued or restricted in some markets due to safety concerns related to long-term use of combined sex hormones. It is available only by prescription and should be used for the shortest duration necessary[5].

Brand names
Covaryx HSEssianEstratestMenogenSyntest D.S.Syntest H.S.EEMTEEMT HS
Other names
esterified estrogens and methyltestosterone
02

Targets

ER (Estrogen receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on esterified estrogens + methyltestosterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esterified estrogens + methyltestosterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call